Cwm LLC Has $117,000 Position in Teladoc Health, Inc. (NYSE:TDOC)

Cwm LLC grew its position in Teladoc Health, Inc. (NYSE:TDOC) by 31.3% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 5,416 shares of the health services provider’s stock after buying an additional 1,291 shares during the quarter. Cwm LLC’s holdings in Teladoc Health were worth $117,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Commonwealth Equity Services LLC increased its position in Teladoc Health by 5.7% in the 3rd quarter. Commonwealth Equity Services LLC now owns 80,934 shares of the health services provider’s stock valued at $1,505,000 after acquiring an additional 4,344 shares during the period. Raymond James & Associates boosted its stake in shares of Teladoc Health by 0.9% in the 3rd quarter. Raymond James & Associates now owns 228,238 shares of the health services provider’s stock valued at $4,243,000 after purchasing an additional 2,029 shares during the last quarter. Mackenzie Financial Corp boosted its stake in shares of Teladoc Health by 83.7% in the 3rd quarter. Mackenzie Financial Corp now owns 30,843 shares of the health services provider’s stock valued at $570,000 after purchasing an additional 14,050 shares during the last quarter. Allspring Global Investments Holdings LLC boosted its stake in shares of Teladoc Health by 8.8% in the 3rd quarter. Allspring Global Investments Holdings LLC now owns 50,903 shares of the health services provider’s stock valued at $946,000 after purchasing an additional 4,129 shares during the last quarter. Finally, Triumph Capital Management bought a new stake in shares of Teladoc Health in the 3rd quarter valued at $320,000. 76.82% of the stock is currently owned by institutional investors and hedge funds.

Teladoc Health Stock Performance

Shares of TDOC stock opened at $12.80 on Tuesday. The firm has a 50-day moving average of $14.36 and a 200-day moving average of $17.47. The company has a market cap of $2.17 billion, a P/E ratio of -9.08 and a beta of 0.97. The company has a debt-to-equity ratio of 0.67, a current ratio of 3.82 and a quick ratio of 3.74. Teladoc Health, Inc. has a one year low of $12.53 and a one year high of $30.41.

Teladoc Health (NYSE:TDOC) last announced its earnings results on Thursday, April 25th. The health services provider reported ($0.49) EPS for the quarter, missing the consensus estimate of ($0.47) by ($0.02). The firm had revenue of $646.13 million during the quarter, compared to analysts’ expectations of $637.31 million. Teladoc Health had a negative net margin of 8.90% and a negative return on equity of 10.13%. The business’s revenue for the quarter was up 2.7% on a year-over-year basis. During the same quarter in the prior year, the company earned ($0.37) EPS. Equities research analysts forecast that Teladoc Health, Inc. will post -1.04 EPS for the current fiscal year.

Analyst Ratings Changes

A number of research firms have recently commented on TDOC. Oppenheimer reduced their price objective on shares of Teladoc Health from $26.00 to $21.00 and set an “outperform” rating on the stock in a research note on Friday, April 26th. Truist Financial reduced their price objective on shares of Teladoc Health from $23.00 to $17.00 and set a “hold” rating on the stock in a research note on Wednesday, March 6th. Leerink Partnrs reissued a “market perform” rating on shares of Teladoc Health in a research note on Monday, February 26th. Cantor Fitzgerald started coverage on shares of Teladoc Health in a research note on Thursday, February 29th. They set an “overweight” rating and a $22.00 target price on the stock. Finally, Needham & Company LLC restated a “hold” rating on shares of Teladoc Health in a report on Friday, April 26th. Twelve analysts have rated the stock with a hold rating and six have assigned a buy rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus price target of $18.73.

Insider Buying and Selling

In related news, CEO Jason N. Gorevic sold 53,755 shares of the firm’s stock in a transaction dated Monday, March 4th. The shares were sold at an average price of $14.52, for a total transaction of $780,522.60. Following the completion of the sale, the chief executive officer now owns 653,073 shares in the company, valued at $9,482,619.96. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. In other Teladoc Health news, insider Laizer Kornwasser sold 10,411 shares of the stock in a transaction dated Thursday, May 2nd. The shares were sold at an average price of $12.69, for a total transaction of $132,115.59. Following the completion of the transaction, the insider now owns 86,070 shares in the company, valued at $1,092,228.30. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO Jason N. Gorevic sold 53,755 shares of the stock in a transaction dated Monday, March 4th. The stock was sold at an average price of $14.52, for a total transaction of $780,522.60. Following the transaction, the chief executive officer now owns 653,073 shares of the company’s stock, valued at approximately $9,482,619.96. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 138,368 shares of company stock worth $1,989,227. Insiders own 0.95% of the company’s stock.

Teladoc Health Company Profile

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.